Literature DB >> 8482440

Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology.

E Arranz1, A Ferguson.   

Abstract

BACKGROUND: Patients with celiac disease have immunoglobulin (Ig) M antibodies and IgA antigliadin antibody in gut secretions; this pattern of intestinal immunity may be a marker of latent celiac disease. Its frequency in patients referred for jejunal biopsy has been examined.
METHODS: Serum IgG and IgA antigliadin antibody, jejunal fluid IgA and IgM antibodies to gliadin, ovalbumin and beta lactoglobulin, and jejunal fluid IgA and IgM concentrations were measured by enzyme-linked immunosorbent assay.
RESULTS: Seventeen of 19 celiac patients on normal diet and 16 of 23 on gluten-free diet had the celiaclike antibody pattern, as did 41 of 217 other patients. Jejunal biopsy histology had been classified as normal in 38 of these, with minor abnormalities in 3; however, intraepithelial lymphocyte (IEL) counts were high in 13 cases. Trial of a gluten-free diet produced clinical improvement in 6 of 7 antibody-positive patients. After extra dietary gluten, one developed subtotal villous atrophy.
CONCLUSIONS: The celiaclike intestinal antibody pattern and a high IEL count may be markers of latent gluten-sensitive enteropathy; some of these patients are clinically gluten sensitive in the absence of enteropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482440     DOI: 10.1016/0016-5085(93)90333-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group.

Authors:  C Farré; P Humbert; P Vilar; V Varea; X Aldeguer; J Carnicer; M Carballo; M A Gassull
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 2.  Do you still need a biopsy to diagnose celiac disease?

Authors:  S Guandalini; P Gupta
Journal:  Curr Gastroenterol Rep       Date:  2001-10

3.  Frequency of celiac disease in individuals with Down syndrome in the United States.

Authors:  J Mackey; W R Treem; G Worley; A Boney; P Hart; P S Kishnani
Journal:  Clin Pediatr (Phila)       Date:  2001-05       Impact factor: 1.168

4.  Measurement of faecal immunoglobulin a levels in young children.

Authors:  Carine Dion; Paul Montagne; Marie Christine Bene; Gilbert Faure
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

5.  Distal duodenum versus duodenal bulb: intraepithelial lymphocytes have something to say in celiac disease diagnosis.

Authors:  Ana De Andrés; Cristina Camarero; Garbiñe Roy
Journal:  Dig Dis Sci       Date:  2014-11-04       Impact factor: 3.199

6.  Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin.

Authors:  P Moayyedi; S O'Mahony; P Jackson; D A Lynch; M F Dixon; A T Axon
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

7.  Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant?

Authors:  S Mahadeva; J I Wyatt; P D Howdle
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

8.  Screening for coeliac disease: the meaning of low titers of anti-gliadin antibodies (AGA) in non-coeliac children.

Authors:  M Bonamico; G Ballati; P Mariani; M Latini; P Triglione; I Rana; E Porro; M A Mesturino; S Criscione
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 9.  Association of Crohn's disease and latent celiac disease: a case report and review of the literature.

Authors:  Jörg Schedel; Felix Rockmann; Tim Bongartz; Matthias Woenckhaus; Jürgen Schölmerich; Frank Kullmann
Journal:  Int J Colorectal Dis       Date:  2004-12-01       Impact factor: 2.571

10.  Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin.

Authors:  M ten Dam; Y Van De Wal; M L Mearin; Y Kooy; S Peña; J W Drijfhout; F Koning; M Van Tol
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.